Clinical Trial Update: Bevacizumab/Ph 2 for Locally Advanced Head and Neck Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating bevacizumab in locally advanced head and neck squamous cell carcinoma; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: Carcinoma, Squamous Cell of Head and Neck | Phase 2 | Status: COMPLETED | Results posted: 2024-02-14